Skip to main content

HealthCare Global Enterprises Limited (HCG.NS)

National Stock Exchange of India Healthcare Medical - Care FacilitiesView data quality →
46.7Fair

ValueMarkers Composite Index

Top 17%#36,946 of 44,707
Undervalued

75% below intrinsic value ($26)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-2.57
Low Risk
Altman
3.39
Safe
DCF Value
$26
Undervalued
ROIC
18.4%
Strong
P/E
409.7
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

HealthCare Global Enterprises Limited (HCG.NS) — VMCI valuation read

Headline read on HCG.NS: VMCI of 47/100 versus a Healthcare sector median of 50. The 3-point below-median position is what makes HealthCare Global Enterprises Limited a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on HCG.NS: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on HCG.NS: value (HCG.NS trades at 19.0x earnings, 6% above the Healthcare median of 18.0x), quality (ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of -0.6x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.

HCG.NS rose 0.5% over the trailing 7 days, with a -1.0% read on a 30-day basis.

HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2021, it operated 23 cancer centers, including 1 center of excellence in Bengaluru, 2 freestanding diagnostic centers, and 1 day care chemotherapy center across India, as well as 1 cancer center in Africa. The company was founded in 1989 and is based in Bengaluru, India.

CEO: Manish Mattoo6,150 employeesINwww.hcgel.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in HCG.NS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.